Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients
| Status: | Terminated |
|---|---|
| Conditions: | Chronic Pain, Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology, Musculoskeletal |
| Healthy: | No |
| Age Range: | 20 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | March 2012 |
| End Date: | July 2013 |
Effect of Intravenous Acetaminophen on Postoperative Pain of Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Placebo-Controlled Trial
Bariatric patients usually require the use of either intravenous or oral opioid medications.
The use of opioids, however, is often associated with side-effects such as nausea, sedation
pruritus, urinary retention and respiratory depression with often delay patient discharge.
This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to
determine if this will decrease the use of opioids post-operatively for pain management in
morbidly obese patients undergoing laparoscopic bariatric surgery.
The use of opioids, however, is often associated with side-effects such as nausea, sedation
pruritus, urinary retention and respiratory depression with often delay patient discharge.
This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to
determine if this will decrease the use of opioids post-operatively for pain management in
morbidly obese patients undergoing laparoscopic bariatric surgery.
Inclusion Criteria:
- Morbidly Obese and body mass index (BMI) of 35
- Between ages 20-17
- Candidates for Laparoscopic Bariatric Surgery
Exclusion Criteria:
- know hypersensitivity to acetaminophen or opioids
- impairment in liver function
- renal dysfunction
- mental retardation
We found this trial at
1
site
Click here to add this to my saved trials
